Cargando…
Optimal management of the high risk surgical patient: beta stimulation or beta blockade?
Several groups of investigators have shown that peri-operative goal directed therapy (GDT) may reduce mortality in high-risk surgical patients. GDT usually requires the use of beta-adrenergic agents, however, and these may also carry the risk of cardiac ischemia, especially in patients with ischemic...
Autor principal: | De Backer, Daniel |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1414024/ https://www.ncbi.nlm.nih.gov/pubmed/16356257 http://dx.doi.org/10.1186/cc3930 |
Ejemplares similares
-
To beta block or not to beta block; that is the question
por: Ince, Can
Publicado: (2015) -
Beta-adrenergic receptor blockade in angiosarcoma: Which beta-blocker to choose?
por: Embaby, Alaa, et al.
Publicado: (2022) -
Beta-Adrenergic Blockade in Critical Illness
por: Bruning, Rebecca, et al.
Publicado: (2021) -
Beta 2 antagonism in acute respiratory failure
por: Sweeney, Rob Mac, et al.
Publicado: (2010) -
Advances in protocolising management of high risk surgical patients
por: Bennett, E David
Publicado: (2006)